Download presentation
Presentation is loading. Please wait.
Published byRuth Madalena Mota Modified over 5 years ago
1
Azathioprine, 6-mercaptopurine in inflammatory bowel disease: Pharmacology, efficacy, and safety
Marla C. Dubinsky Clinical Gastroenterology and Hepatology Volume 2, Issue 9, Pages (September 2004) DOI: /S (04) Copyright © 2004 American Gastroenterological Association Terms and Conditions
2
Figure 1 Thiopurine metabolism. Oral AZA is rapidly converted to 6-MP by a nonenzymatic process.19 Initial 6-MP transformations occur along competing catabolic (XO, xanthine oxidase; TPMT) and anabolic (HPRT, hypoxanthine phosphoribosyltransferase) enzymatic pathways. Once formed, 6-thiosine 5′-monophosphate (6-TImP) is further catalyzed by inosine monophosphate dehydrogenase (IMPDH) and guanosine monophosphate synthetase (GMPS) and the di- and tri- derivatives of 6-thioguanosine 5′monophosphate (6-TGMP) formed by their respective kinases. 6-TU, 6-thiouric acid. Clinical Gastroenterology and Hepatology 2004 2, DOI: ( /S (04) ) Copyright © 2004 American Gastroenterological Association Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.